Qiang Xiaoling相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

A comparative analysis of HMGB1 and pCTS-L immunomodulatory properties in human peripheral blood mononuclear cells

人外周血单核细胞中HMGB1和pCTS-L免疫调节特性的比较分析

期刊:Frontiers in Immunology

影响因子:5.9

doi:10.3389/fimmu.2026.1764230

Lou, Li; Qiang, Xiaoling; Zhu, Cassie Shu; Xiong, Brian; Chen, Weiqiang; Li, Jianhua; Tracey, Kevin J; Wang, Haichao

细胞生物学

免疫/内分泌

发表日期：2026

文献求助收藏

Pro-dermcidin and derivatives as potential therapeutics for lethal experimental sepsis

皮苷原及其衍生物作为致命性实验性脓毒症的潜在治疗药物

期刊:Frontiers in Immunology

影响因子:5.9

doi:10.3389/fimmu.2025.1621633

Chen, Weiqiang; Qiang, Xiaoling; Zhu, Cassie Shu; Li, Jianhua; Lou, Li; Wang, Ping; Tracey, Kevin J; Wang, Haichao

发表日期：2025

文献求助收藏

Pro-Dermcidin as an Emerging Regulator of Innate Immunity in Sepsis.

前皮肤素作为脓毒症先天免疫的新兴调节因子

期刊:International Journal of Molecular Sciences

影响因子:4.9

doi:10.3390/ijms26157643

Lou Li, Li Jianhua, Chen Weiqiang, Zhu Cassie Shu, Qiang Xiaoling, Wang Haichao

免疫/内分泌

发表日期：2025

文献求助收藏

Repurposing a Detrimental Antibody Epitope as Targeted Therapeutics for Sepsis and Rheumatoid Arthritis

将有害抗体表位重新用于治疗脓毒症和类风湿性关节炎

doi:10.21203/rs.3.rs-7633404/v1

Chen, Weiqiang; Lou, Li; Qiang, Xiaoling; Zhu, Cassie Shu; Li, Jianhua; Chen, Shujin; Xiong, Brian; Yang, Huan; Wang, Ping; Tracey, Kevin J; Wang, Haichao

发表日期：2025

文献求助收藏

Connexin 43 and Pannexin 1 hemichannels as endogenous regulators of innate immunity in sepsis

连接蛋白43和Pannexin 1半通道作为脓毒症中先天免疫的内源性调节因子

期刊:Frontiers in Immunology

影响因子:5.9

doi:10.3389/fimmu.2024.1523306

Li, Jianhua; Lou, Li; Chen, Weiqiang; Qiang, Xiaoling; Zhu, Cassie; Wang, Haichao

免疫/内分泌

发表日期：2024

文献求助收藏

Elevated Circulating Procathepsin L as a Potential Biomarker of Inflamm-aging

循环中原组织蛋白酶L水平升高可作为炎症衰老的潜在生物标志物

期刊:Medical Hypotheses

影响因子:0.8

doi:10.1016/j.mehy.2024.111322

Zhu, Cassie Shu; Chen, Weiqiang; Qiang, Xiaoling; Lou, Li; Li, Jianhua; Wang, Haichao

发表日期：2024

文献求助收藏

A two-decade journey in identifying high mobility group box 1 (HMGB1) and procathepsin L (pCTS-L) as potential therapeutic targets for sepsis

二十年来，人们一直在探索高迁移率族蛋白1 (HMGB1) 和前组织蛋白酶L (pCTS-L) 作为脓毒症潜在治疗靶点的可能性。

期刊:Expert Opinion on Therapeutic Targets

影响因子:4.4

doi:10.1080/14728222.2023.2239495

Li, Jianhua; Zhu, Cassie Shu; He, Li; Qiang, Xiaoling; Chen, Weiqiang; Wang, Haichao

发表日期：2023

文献求助收藏

Monoclonal antibodies capable of binding SARS-CoV-2 spike protein receptor-binding motif specifically prevent GM-CSF induction

能够与SARS-CoV-2刺突蛋白受体结合基序特异性结合的单克隆抗体可阻止GM-CSF的诱导。

期刊:Journal of Leukocyte Biology

影响因子:3.1

doi:10.1002/JLB.3COVCRA0920-628RR

Qiang, Xiaoling; Zhu, Shu; Li, Jianhua; Chen, Weiqiang; Yang, Huan; Wang, Ping; Tracey, Kevin J; Wang, Haichao

单克隆抗体

发表日期：2022

文献求助收藏

Identification of tetranectin-targeting monoclonal antibodies to treat potentially lethal sepsis.

鉴定靶向四联蛋白的单克隆抗体，用于治疗可能致命的败血症

期刊:Science Translational Medicine

影响因子:14.6

doi:10.1126/scitranslmed.aaz3833

Chen Weiqiang, Qiang Xiaoling, Wang Yongjun, Zhu Shu, Li Jianhua, Babaev Ariella, Yang Huan, Gong Jonathan, Becker Lance, Wang Ping, Tracey Kevin J, Wang Haichao

发表日期：2020

文献求助收藏

Monoclonal Antibodies Capable of Binding SARS-CoV-2 Spike Protein Receptor Binding Motif Specifically Prevent GM-CSF Induction.

能够特异性结合 SARS-CoV-2 刺突蛋白受体结合基序的单克隆抗体可阻止 GM-CSF 的诱导

doi:10.1101/2020.09.04.280081

Qiang Xiaoling, Zhu Shu, Li Jianhua, Wang Ping, Tracey Kevin J, Wang Haichao

发表日期：2020

文献求助收藏